{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:39Z","timestamp":1791218139415,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.1097\/qai.0b013e3181c3cbf0","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:34:33Z","timestamp":1268890473000},"page":"71-77","source":"Crossref","is-referenced-by-count":31,"title":["Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006"],"prefix":"10.1097","volume":"54","author":[{"given":"Barudi","family":"Mosimaneotsile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anikie","family":"Mathoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bafanana","family":"Chengeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tefera B","family":"Agizew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zegabriel","family":"Tedla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oaitse I","family":"Motsamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Kilmarx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraz","family":"Samandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210131","first-page":"55","article-title":"Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998.","volume":"6","author":"Ansari","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"Suppl 1","key":"R3-10-20210131","first-page":"92","article-title":"Baseline evaluation of routine HIV testing among tuberculosis patients in Botswana, 2005.","volume":"12","author":"Gammino","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R4-10-20210131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/421388","article-title":"Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002.","volume":"39","author":"Talbot","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R5-10-20210131","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"R6-10-20210131","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"R7-10-20210131","first-page":"361","article-title":"Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease.","volume":"68","year":"1993","journal-title":"Weekly Epidemiol Rec"},{"key":"R9-10-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11908-008-0012-0","article-title":"Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana.","volume":"10","author":"Ojikutu","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"R10-10-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R11-10-20210131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R12-10-20210131","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"R13-10-20210131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"key":"R14-10-20210131","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/JCM.42.10.4536-4544.2004","article-title":"High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study.","volume":"42","author":"Easterbrook","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R15-10-20210131","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00002030-199707000-00011","article-title":"Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya.","volume":"11","author":"Gilks","year":"1997","journal-title":"AIDS"},{"key":"R16-10-20210131","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1086\/431517","article-title":"The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi.","volume":"192","author":"Glynn","year":"2005","journal-title":"J Infect Dis"},{"key":"R20-10-20210131","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(03)14745-9","article-title":"Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana.","volume":"362","author":"Mosimaneotsile","year":"2003","journal-title":"Lancet"},{"key":"R21-10-20210131","first-page":"270","article-title":"INH preventive therapy among adult HIV-infected patients in Thailand.","volume":"9","author":"Hiransuthikul","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"R22-10-20210131","first-page":"326","article-title":"Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda.","volume":"6","author":"Lugada","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"R23-10-20210131","first-page":"761","article-title":"Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda.","volume":"10","author":"Mugisha","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R24-10-20210131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199707313370505","article-title":"A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.","volume":"337","author":"Gordin","year":"1997","journal-title":"N Engl J Med"},{"key":"R25-10-20210131","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00002030-199707000-00006","article-title":"Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.","volume":"11","author":"Hawken","year":"1997","journal-title":"AIDS"},{"key":"R26-10-20210131","first-page":"991","article-title":"Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.","volume":"117","author":"Kopanoff","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"R27-10-20210131","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"R28-10-20210131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/ajrccm\/145.2_Pt_1.494","article-title":"Isoniazid-associated hepatitis deaths: a review of available information.","volume":"145","author":"Snider","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R29-10-20210131","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.1979.03290380015017","article-title":"Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.","volume":"241","author":"Byrd","year":"1979","journal-title":"JAMA"},{"key":"R30-10-20210131","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","article-title":"Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?","volume":"17","author":"Churchyard","year":"2003","journal-title":"AIDS"},{"key":"R31-10-20210131","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity.","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"R32-10-20210131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e31802f8512","article-title":"Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study.","volume":"44","author":"Corey","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-10-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"R34-10-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00126334-200501010-00003","article-title":"Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults.","volume":"38","author":"Laurent","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-10-20210131","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.qai.0000159668.80207.5b","article-title":"Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.","volume":"40","author":"Wester","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-10-20210131","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0895-4356(98)00033-X","article-title":"Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. Uganda-Case Western Reserve University Research Collaboration.","volume":"51","author":"Pekovic","year":"1998","journal-title":"J Clin Epidemiol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3181c3cbf0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:51Z","timestamp":1786040031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201005010-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181c3cbf0","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}